½ÃÀ庸°í¼­
»óǰÄÚµå
1689813

¼¼°èÀÇ È¯ÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀå : Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ°ú Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Global Patient-centric Health Care App - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀå ±Ô¸ð´Â 2025³â 261¾ï 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£(2025-2030³â) Áß CAGR 40.11%·Î È®´ëµÇ¾î, 2030³â¿¡´Â 1,410¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Patient-centric Health Care App-Market-IMG1

COVID-19ÀÇ ´ëÀ¯ÇàÀº ÀÇ·á »ê¾÷¿¡ ¿µÇâÀ» ÁÖ¾ú½À´Ï´Ù. COVID-19ÀÇ À¯ÇàÀº ¸ðµç »ê¾÷ ºÎ¹®ÀÇ È¥¶õ, °úÁ¦, Á¦ÇÑ, º¯È­¿¡ ¿¬°áµÇ¾ú½À´Ï´Ù.

µû¶ó¼­ ȯÀÚ´Â ´ç´¢º´À̳ª °íÇ÷¾Ð µîÀÇ ¸¸¼º ÁúȯÀ» °ü¸®Çϱâ À§ÇØ ¾ÛÀ» ÀÌ¿ëÇÏ´Â °æÇâÀÌ °­ÇØÁ³À¸¸ç, COVID-19 °ü¸®¸¦ À§ÇØ ¸¹Àº ȯÀÚ ÄÉ¾î ¾ÛÀÌ ½ÃÀ۵Ǿú½À´Ï´Ù.

¿¹¸¦ µé¾î 2020³â 12¿ù Journal of Medical Internet Research¿¡ °ÔÀçµÈ Haridimos Kondylakis µîÀÇ Á¶»ç ¿¬±¸¿¡ µû¸£¸é ¸ð¹ÙÀÏ ¾ÛÀº º´¿ø ºÎ´ã °¨¼Ò, °³ÀÎ Áõ»ó ¹× Á¤½Å »óÅ ÃßÀû, ½Å·ÚÇÒ ¼öÀÖ´Â Á¤º¸¿¡ ´ëÇÑ ¾×¼¼½º Á¦°ø, »õ·Î¿î ¿¹Ãø ÀÎÀÚ ¹ß°ß µî À¯Çà¿¡ ÀÇÇØ ºÎ°úµÈ ½É°¢ÇÑ °úÁ¦¿¡ Á÷¸éÇÏ´Â ÀÇ·á Àü¹®°¡, ½Ã¹Î, ÀÇ»ç °áÁ¤ÀÚ¿¡°Ô À־ ±ÍÁßÇÑ ÅøÀ̶ó°í »ý°¢µÇ¾î ÀÇ·á Á¦°ø¾÷ü¿Í ¼ÒºñÀÚ ¸ðµÎ·ÎºÎÅÍ »ê¾÷ Àüü¿¡¼­ ¸ð¹ÙÀÏ Çコ ¾ÛÀÇ ³ôÀº ä¿ëÀ¸·Î À̾îÁ³½À´Ï´Ù.

½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ƯÈ÷ ³ëÀÎÃþ¿¡¼­ ¾Ï, ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿° µîÀÇ ¸¸¼º ÁúȯÀÇ ¹ß»ý·ü Áõ°¡¸¦ Æ÷ÇÔÇÕ´Ï´Ù.

¿¹¸¦ µé¾î IDF Diabetes Atlas Tenth edition 2021³â¿¡ µû¸£¸é 2021³â¿¡´Â ¾à 5¾ï 3,700¸¸ ¸íÀÇ ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖ½À´Ï´Ù.

2021³â 10¿ù¿¡ ¹ßÇ¥µÈ ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2015-2050³â±îÁö ¼¼°èÀÇ 60¼¼ ÀÌ»óÀÇ Àα¸ ºñÀ²Àº 12%¿¡¼­ 22%·Î °ÅÀÇ µÎ¹è·Î ´Ã¾î³ª °í·ÉÀÚÀÇ 80%´Â Àú¼Òµæ ¹× Á߼ҵ汹¿¡ »ì°Ô µË´Ï´Ù. ¾î´À ³ª¶óµµ, ÀÇ·á »çȸ ½Ã½ºÅÛÀÌ ÀÌ Àα¸ µ¿ÅÂÀÇ º¯È­¸¦ ÃÖ´ëÇÑ È°¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â Å« °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. À̰ÍÀÌ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿Í °°ÀÌ, ³ëÀÎ Áõ°¡, ÀüÀÚ Â÷Æ® ½Ã½ºÅÛÀ» À¯ÁöÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ³ô¾Æ, Åõ¾à ¹Ì½º¸¦ ȸÇÇÇϱâ À§ÇÑ ±â¼ú ±â¹ÝÀÇ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£µ¿¾È ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀåÀ» °ßÀÎÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀå µ¿Çâ

ÀüÈ­ ±â¹Ý ¾Û ÇÏÀ§ ºÎ¹®ÀÌ È¯ÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀå¿¡¼­ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ Àü¸Á

¿¹Ãø ±â°£ µ¿¾È ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀå Àü¹Ý¿¡ °ÉÃÄ ÀüÈ­ ±â¹Ý ¾ÛÀÌ ÃÖ´ë ¼öÀÍ °øÀ¯¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

COVID-19 ÆÒµ¥¹Í 2020 µ¿¾È ÀÇ·á, Çູ, »çȸÀû ¿¬°áÀÇ À¯Áö´Â ³ëÀο¡°Ô ¸Å¿ì Áß¿äÇß½À´Ï´Ù. Dina M. El-Sherif & MohamedAbouzid°¡ 2022³â 6¿ù¿¡ ¹ßÇ¥ÇÑ Á¶»ç ¿¬±¸¿¡ µû¸£¸é, ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀº COVID-19 ÆÒµ¥¹Í µ¿¾È COVID-19 ÀÌ¿ÜÀÇ °ü¸®³ª ȯÀÚ¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇß½À´Ï´Ù. 2021³â 1¿ù, Dell Technologies´Â º¸°Ç°¡Á· º¹ÁöºÎ¿Í Tata Trusts¿Í °øµ¿À¸·Î Àü±¹ Á¤ºÎ 1Â÷ ÀÇ·á¼¾ÅÍ(PHC)¿¡¼­ ºñ°¨¿°¼º ÁúȯÀ» °ü¸®Çϱâ À§ÇÑ ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼Ǹ¦ °³¹ßÇß½À´Ï´Ù.

¼¼°èÀûÀ¸·Î ½º¸¶Æ®Æù »ç¿ëÀÚÀÇ º¸±ÞÀÌ ÁøÇàµÇ°í ¿ø°Ý ÀÇ·á ¹× ¸ð¹ÙÀÏ Çコ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö´Â °¡¿îµ¥, ¿ø°Ý ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ±â¾÷ÀÌ ¸ðµç ÀÌÁ¡À» °®Ãá ¿ëµµ¸¦ Ãâ½ÃÇϱ⠶§¹®¿¡ ÀüÈ­ ±â¹ÝÀÇ °Ç°­ ¿ëµµ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀüÈ­ ±â¹Ý °Ç°­ °ü¸® ¿ëµµÀÇ ´Ù¸¥ ÀÌÁ¡Àº ´ëÈ­Çü, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º, Áø´Ü¿¡¼­ °áÁ¦±îÁöÀÇ ÅëÇÕ ¼Ö·ç¼Ç, »ç¿ëÀÚÀÇ ÃֽŠÁ¤º¸¸¦ À¯ÁöÇϱâÀ§ÇÑ Á¤±âÀûÀÎ ÅëÁö, Á¦°ø¾÷ü ¹× ±â´É¿¡ µû¶ó ÀüÈ­ ±â¹Ý °Ç°­ °ü¸® ¿ëµµ¸¦ ÀÎÅͳݾøÀÌ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡, ¿¹Ãø±â°£ µ¿¾Èµµ ¸¶Âù°¡Áö·Î ¿¹Ãø

ºÏ¹Ì´Â ¿¹Ãø±â°£À» ÅëÇØ ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û(PCHA) ½ÃÀå Àüü¸¦ Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ ½ÉÀ庴ÇÐȸ(American College of Cardiology Foundation) 2021¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2020³â COVID-19 À¯¹æ±³È¯½Ã °íÇ÷¾Ð¼º Áúȯ°ú ÇãÇ÷¼º ½ÉÀåÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ Áõ°¡ÇÏ¿´À¸¸ç, ¹Ì±¹¿¡¼­ À¯Çິ ½Ã ȯÀÚ Á᫐ ÀÇ·á ¾ÛÀÌ Áúº´ °ü¸®¿¡ »ç¿ëµÇ°Ô µÇ¾ú½À´Ï´Ù.

°í·ÉÀÚ Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ Å« µ¿±¹Àº ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¿ä±¸°¡ ÀÖÀ¸¸ç, ȯÀÚ Á᫐ ÇコÄÉ¾î ¾ÛÀº ¾ð¸ÞÆ® ¿ä±¸¸¦ ÃæÁ·Çϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ô´Ù°¡ ÀÇ·á ÁöÃâ Áõ°¡, °Ç°­ ÀǽÄ, ÀÓ»ó Áß½ÉÀÇ Ä¡·á¿¡¼­ ȯÀÚ Áß½É Ä¡·á·ÎÀÇ ½ÃÇÁÆ®°¡ ÀÌ Áö¿ª ½ÃÀåÀ» ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.

ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û »ê¾÷ °³¿ä

ȯÀÚ Á᫐ ÇコÄÉ¾î ¾Û ½ÃÀåÀÇ °æÀïÀº Áß°£ Á¤µµÀÔ´Ï´Ù. ½ÃÀå Æ÷Áö¼ÇÀ» È®´ëÇϰí ÀÖ´Â ±â¾÷µµ ÀÖ½À´Ï´Ù. ½ÃÀå ±â¾÷¿¡´Â Koninklijke Philips N V, Merck & Co. Inc., Hill-Rom Holdings Inc., Bayer AG, Siemens Healthineers AG µîÀÌ ÀÖ½À´Ï´Ù.

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå °³¿ä
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Áõ°¡
    • ½Å±â¼ú¿¡ ÀÇÇÑ ¾×¼¼½ºÀÇ Çâ»ó°ú À¯¿¬¼º
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °³¹ß ºñ¿ëÀÇ ³ôÀÌ
    • ÀÏ¹Ý ÀÇ·á Á¦°ø¾÷ü¿¡ ÀÇÇÑ ¼Ò±ØÀû ÀÚ¼¼
  • Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚ/¼ÒºñÀÚÀÇ Çù»ó·Â
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°èÀÇ °­µµ

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

  • ¿î¿µ Çüź°
    • ÀüÈ­ ±â¹Ý
    • À¥ ±â¹Ý
    • ÇÏÀ̺긮µå ȯÀÚ Á᫐ ¾Û
  • ¿ëµµº°
    • À£´Ï½º °ü¸®
    • Áúº´ ¹× Ä¡·á °ü¸®
    • ±âŸ
  • Áö¿ªº°
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
    • À¯·´
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • GCC ±¹°¡
      • ³²¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¹Ì
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ³²¹Ì

Á¦6Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Boston Scientific Corporation
    • Assurecare LLC(IPatient Care)
    • Merck & Co. Inc.
    • MobileSmith Inc.
    • Koninklijke Philips NV
    • Pfizer Inc.
    • Siemens Healthineers AG
    • Novartis AG
    • Bayer AG
    • Baxter International Inc.(hillrom Services, Inc.)
    • athenahealth Inc.
    • Allscripts Healthcare Solutions Inc.
    • International Business Machines Corporation(IBM)
    • Mfine Pvt. Ltd
    • Oracle(cerner Corporation)

Á¦7Àå ½ÃÀå ±âȸ¿Í ¾ÕÀ¸·ÎÀÇ µ¿Çâ

JHS 25.05.07

The Global Patient-centric Health Care App Market size is estimated at USD 26.13 billion in 2025, and is expected to reach USD 141.09 billion by 2030, at a CAGR of 40.11% during the forecast period (2025-2030).

Global Patient-centric Health Care App - Market - IMG1

The COVID-19 pandemic had an impact on the healthcare industry. The outbreak of COVID-19 led to disruption, challenges, limitations, and changes in every industry sector. The pandemic also impacted the studied market. The outbreak of COVID-19 showed a positive impact on the market, as lockdowns led to the lower availability of doctors in clinical settings.

Thus, patients were more inclined to use apps to manage their chronic conditions, such as diabetes, hypertension, and other chronic diseases. Moreover, there have been a large number of patient care apps launched for COVID-19 management. Nationwide lockdowns resulted in providing healthcare services by the hospitals and clinics, which led to the rise in the use of patient-centric healthcare app that aims toward the management of diseases.

For instance, according to a research study by Haridimos Kondylakis et al., published in the Journal of Medical Internet Research in December 2020, mobile apps were considered to be a valuable tool for health professionals, citizens, and decision-makers in facing critical challenges imposed by the pandemic such as reducing the burden on hospitals, tracking the symptoms and mental health of individuals, providing access to credible information, and discovering new predictors, leading to the high adoption of mobile health apps across the industry both from providers and consumers.

The major factors driving the market growth include the increased incidence of chronic disorders, such as cancers, diabetes, and rheumatoid arthritis, especially in the geriatric population. Treating chronic diseases requires continuous monitoring and evaluation of physiological changes for proper diagnosis and medication.

For instance, as per the IDF Diabetes Atlas Tenth edition 2021, in 2021, about 537 million adults were living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The increasing number of diabetes patients drives them to demand more monitoring apps and drives the market

According to World Health Organization (WHO) data published in October 2021, between 2015 and 2050, the proportion of the global population over 60 years will nearly double from 12% to 22% in 2050, and 80% of older people will be living in low- and middle-income countries. All countries face major challenges in ensuring their health and social systems are ready to make the most of this demographic shift. Thus, healthcare apps come in the role of monitoring vital parameters. This is expected to drive the market. Thus, the growing elderly population, rise in government initiatives to maintain electronic health record systems, and increased demand for technology-based treatment to avoid medication errors are likely to drive the patient-centric healthcare app (PCHA) market over the forecast period.

Patient Centric Healthcare App Market Trends

The Phone-based Apps Sub-segment is Expected to Hold Significant Market Share in the Patient-centric Healthcare App Market

The phone-based apps are expected to account for the largest revenue share in the overall patient-centric healthcare app market over the forecast period.

During the COVID-19 pandemic 2020, the maintenance of healthcare, well-being, and the social connection was crucial for the elderly population. Many mobile health apps were launched after countries relaxed their telehealth regulations to combat the COVID-19 pandemic. Mobile health apps help patients with their health conditions, and physicians deliver the services on their premises. According to the research study published in June 2022 by Dina M. El-Sherif& Mohamed Abouzid, mobile applications played a crucial role during the COVID-19 pandemic in management and patients other than COVID-19. Additionally, in January 2021, in India, Dell Technologies, in collaboration with the Ministry of Health and Family Welfare and Tata Trusts, developed a mobile application to manage non-communicable diseases at the government primary health centers (PHCs) across the country.

With the growing penetration of smartphone users globally and increasing demand for telehealth and mobile health services, the phone-based health application segment is expected to grow over the forecast period as companies offering telehealth services launch their applications with all the benefits.

Other advantages of phone-based health applications include an interactive and user-friendly interface, integrated solutions from consultation to payment, regular notification to keep the user updated, and depending upon the provider and function, phone-based healthcare applications can also be used without the internet. All these factors are collectively expected to boost growth in the studied segment over the forecast period.

North America Dominates the Market and Expected to do the Same in the Forecast Period.

North America is expected to dominate the overall patient-centric healthcare app (PCHA) market throughout the forecast period. The dominance is due to the region's huge target population base with chronic diseases, such as coronary heart diseases, atrial fibrillation, stroke, hypertension, and diabetes.

As per the American College of Cardiology Foundation 2021, deaths from hypertensive diseases and ischemic heart disease in the United States increased during the COVID-19 pandemic in 2020, leading to the increasing use of patient-centric health care apps during the pandemic in the United States in the management of the disease.

The rising geriatric population and the country's high burden of chronic diseases are expected to boost market growth. For instance, Heart disease is the main cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC) September 2020. Around 805,000 Americans experience a heart attack each year. As the number of deaths due to heart diseases is increasing, there is a continuous need for the proper monitoring of cardiac diseases, and patient-centric healthcare apps fulfill the unmet needs; hence it is expected to show growth over the forecast period. Additionally, According to the American Diabetes Federation 2019 report, an estimated 463 million adults live with diabetes worldwide, which is estimated to reach 700 million by 2045.

Furthermore, a rise in healthcare expenditure, health awareness, and a shift from clinical-centric treatment to patient-centric care boost the market in the region. The growing adoption of technology by key healthcare providers in the region is expected to contribute to a significant global market share throughout the forecast period.

Patient Centric Healthcare App Industry Overview

The patient-centric healthcare app market is moderately competitive. Some companies are expanding their market position while others are adopting various strategies, such as mergers and acquisitions, introducing new products, and upgrading technologies, to maintain their market position. Some market players are Koninklijke Philips N V, Merck & Co. Inc., Hill-Rom Holdings Inc., Bayer AG, and Siemens Healthineers AG.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases and Rising Geriatric Population
    • 4.2.2 Enhanced Access and Flexibility with Novel Technologies
  • 4.3 Market Restraints
    • 4.3.1 The High Cost of Development
    • 4.3.2 Reluctance by Regular Healthcare Providers
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Mode of Operation
    • 5.1.1 Phone-based
    • 5.1.2 Web-based
    • 5.1.3 Hybrid Patient-centric Apps
  • 5.2 By Application
    • 5.2.1 Wellness Management
    • 5.2.2 Disease And Treatment Management
    • 5.2.3 Other Applications
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Assurecare LLC (IPatient Care)
    • 6.1.3 Merck & Co. Inc.
    • 6.1.4 MobileSmith Inc.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Pfizer Inc.
    • 6.1.7 Siemens Healthineers AG
    • 6.1.8 Novartis AG
    • 6.1.9 Bayer AG
    • 6.1.10 Baxter International Inc. (hillrom Services, Inc.)
    • 6.1.11 athenahealth Inc.
    • 6.1.12 Allscripts Healthcare Solutions Inc.
    • 6.1.13 International Business Machines Corporation (IBM)
    • 6.1.14 Mfine Pvt. Ltd
    • 6.1.15 Oracle (cerner Corporation)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦